These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11567985)

  • 1. Targeted deletion of 5'HS1 and 5'HS4 of the beta-globin locus control region reveals additive activity of the DNaseI hypersensitive sites.
    Bender MA; Roach JN; Halow J; Close J; Alami R; Bouhassira EE; Groudine M; Fiering SN
    Blood; 2001 Oct; 98(7):2022-7. PubMed ID: 11567985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the human beta-globin LCR 5'HS4 or 5'HS1 differentially affects beta-like globin gene expression in beta-YAC transgenic mice.
    Fedosyuk H; Peterson KR
    Blood Cells Mol Dis; 2007; 39(1):44-55. PubMed ID: 17433733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNase I hypersensitivity and epsilon-globin transcriptional enhancement are separable in locus control region (LCR) HS1 mutant human beta-globin YAC transgenic mice.
    Shimotsuma M; Okamura E; Matsuzaki H; Fukamizu A; Tanimoto K
    J Biol Chem; 2010 May; 285(19):14495-503. PubMed ID: 20231293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent formation of DnaseI hypersensitive sites in the murine beta-globin locus control region.
    Bender MA; Mehaffey MG; Telling A; Hug B; Ley TJ; Groudine M; Fiering S
    Blood; 2000 Jun; 95(11):3600-4. PubMed ID: 10828050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the core region of 5' HS2 of the mouse beta-globin locus control region reveals a distinct effect in comparison with human beta-globin transgenes.
    Hu X; Bulger M; Bender MA; Fields J; Groudine M; Fiering S
    Blood; 2006 Jan; 107(2):821-6. PubMed ID: 16189270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mouse beta-globin locus control region: hypersensitive sites 3 and 4.
    Jiménez G; Gale KB; Enver T
    Nucleic Acids Res; 1992 Nov; 20(21):5797-803. PubMed ID: 1454540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human beta-globin locus control region confers an early embryonic erythroid-specific expression pattern to a basic promoter driving the bacterial lacZ gene.
    Tewari R; Gillemans N; Harper A; Wijgerde M; Zafarana G; Drabek D; Grosveld F; Philipsen S
    Development; 1996 Dec; 122(12):3991-9. PubMed ID: 9012519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Full activity from human beta-globin locus control region transgenes requires 5'HS1, distal beta-globin promoter, and 3' beta-globin sequences.
    Pasceri P; Pannell D; Wu X; Ellis J
    Blood; 1998 Jul; 92(2):653-63. PubMed ID: 9657768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flanking HS-62.5 and 3' HS1, and regions upstream of the LCR, are not required for beta-globin transcription.
    Bender MA; Byron R; Ragoczy T; Telling A; Bulger M; Groudine M
    Blood; 2006 Aug; 108(4):1395-401. PubMed ID: 16645164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large upstream region is not necessary for gene expression or hypersensitive site formation at the mouse beta -globin locus.
    Farrell CM; Grinberg A; Huang SP; Chen D; Pichel JG; Westphal H; Felsenfeld G
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14554-9. PubMed ID: 11121056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5'HS4 core element of the human beta-globin locus control region is required for high-level globin gene expression in definitive but not in primitive erythropoiesis.
    Navas PA; Peterson KR; Li Q; McArthur M; Stamatoyannopoulos G
    J Mol Biol; 2001 Sep; 312(1):17-26. PubMed ID: 11545582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitive site 2 specifies a unique function within the human beta-globin locus control region to stimulate globin gene transcription.
    Bungert J; Tanimoto K; Patel S; Liu Q; Fear M; Engel JD
    Mol Cell Biol; 1999 Apr; 19(4):3062-72. PubMed ID: 10082573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic and additive properties of the beta-globin locus control region (LCR) revealed by 5'HS3 deletion mutations: implication for LCR chromatin architecture.
    Fang X; Sun J; Xiang P; Yu M; Navas PA; Peterson KR; Stamatoyannopoulos G; Li Q
    Mol Cell Biol; 2005 Aug; 25(16):7033-41. PubMed ID: 16055715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus.
    Fiering S; Epner E; Robinson K; Zhuang Y; Telling A; Hu M; Martin DI; Enver T; Ley TJ; Groudine M
    Genes Dev; 1995 Sep; 9(18):2203-13. PubMed ID: 7557375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual LCR hypersensitive sites cooperate to generate an open chromatin domain spanning the human beta-globin locus.
    Li G; Lim KC; Engel JD; Bungert J
    Genes Cells; 1998 Jul; 3(7):415-29. PubMed ID: 9753424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperativeness of the higher chromatin structure of the beta-globin locus revealed by the deletion mutations of DNase I hypersensitive site 3 of the LCR.
    Fang X; Xiang P; Yin W; Stamatoyannopoulos G; Li Q
    J Mol Biol; 2007 Jan; 365(1):31-7. PubMed ID: 17056066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypersensitive sites of the murine β-globin locus control region act independently to affect nuclear localization and transcriptional elongation.
    Bender MA; Ragoczy T; Lee J; Byron R; Telling A; Dean A; Groudine M
    Blood; 2012 Apr; 119(16):3820-7. PubMed ID: 22378846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human beta-globin locus control region HS5 contains CTCF- and developmental stage-dependent enhancer-blocking activity in erythroid cells.
    Tanimoto K; Sugiura A; Omori A; Felsenfeld G; Engel JD; Fukamizu A
    Mol Cell Biol; 2003 Dec; 23(24):8946-52. PubMed ID: 14645507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing 5'HS3 and 5'HS4 LCR core regions and NF-E2 in Iranian thalassemia intermedia patients with normal or carrier status for beta-globin mutations.
    Neishabury M; Azarkeivan A; Oberkanins C; Abedini SS; Zamani S; Najmabadi H
    Blood Cells Mol Dis; 2011 Mar; 46(3):201-5. PubMed ID: 21232998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of a transcriptional motif of a distant regulatory element reduces the expression of embryonic and fetal globin genes.
    Navas PA; Swank RA; Yu M; Peterson KR; Stamatoyannopoulos G
    Hum Mol Genet; 2003 Nov; 12(22):2941-8. PubMed ID: 14506128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.